Drug Type Bacteriophage therapy |
Synonyms TP 102 |
Target |
Mechanism Enzymes modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic foot infection | Phase 2 | US | 08 Nov 2023 | |
Diabetic foot infection | Phase 2 | IN | 08 Nov 2023 | |
Acinetobacter Infections | Phase 2 | IL | 22 Mar 2021 | |
Diabetic foot ulcer | Phase 2 | IL | 22 Mar 2021 | |
Pseudomonas Infections | Phase 2 | IL | 22 Mar 2021 | |
Staphylococcus Aureus Infections | Phase 2 | IL | 22 Mar 2021 | |
Staphylococcal Infections | Phase 2 | IL | 16 Mar 2021 | |
Ulcer | Phase 1 | - | - |